BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1309 related articles for article (PubMed ID: 17706430)

  • 1. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas--recent progress and future challenges.
    Seddon BM; Davda R
    Eur J Radiol; 2011 Apr; 78(1):30-40. PubMed ID: 21247711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on treatment of uterine sarcoma.
    Nam JH; Park JY
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
    Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
    Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
    Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy of uterine sarcomas].
    Bai P; Zhang W; Sun J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):80-2. PubMed ID: 11776610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of early uterine sarcomas: disentangling adjuvant modalities.
    Zagouri F; Dimopoulos AM; Fotiou S; Kouloulias V; Papadimitriou CA
    World J Surg Oncol; 2009 Apr; 7():38. PubMed ID: 19356236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of sarcomas of the uterus.
    Novetsky AP; Powell MA
    Curr Opin Oncol; 2013 Sep; 25(5):546-52. PubMed ID: 23942299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of patients with sarcoma of the uterus].
    Bokhman IaV; Urmancheeva AF
    Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent radiochemotherapy of locally recurrent or advanced sarcomas of the uterus.
    Kortmann B; Reimer T; Gerber B; Klautke G; Fietkau R
    Strahlenther Onkol; 2006 Jun; 182(6):318-24. PubMed ID: 16703286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
    Hensley ML
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.